Entry expands the reach of Else Brand in Massachusetts as the second listing in the Northeast.
Development significantly strengthens the company’s strategic presence in the northeast.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/89d40943-b5b1-4067-ae1d-e8f056d3fe0c

VANCOUVER, British Columbia, September 01, 2021 (GLOBE NEWSWIRE) – ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Different” or the “Society”) plant-based baby, toddler and child nutrition society, announced that it will expand its complete plant-based nutrition for toddlers to Roche Bros. locations this September.

“The partnership with Roche Bros. is an exciting development for the company,” said Hamutal Yitzhak, co-founder and CEO of Else Nutrition. “We have tried to further strengthen our presence in the Northeast, and Roche Bros. is a great fit for us with premium-seeking, health-conscious customers,” she added.

Roche Bros. is a Massachusetts-based supermarket chain that operates in 21 markets. UNFI sells to the quality-oriented retail chain. Headquartered in Mansfield, Massachusetts, Roche Bros. stores are primarily located in the Metro Boston Area. The Roche Bros flagship is a 25,000 m² site in Boston’s Downtown Crossing and also operates in Connecticut. Their newest location is in Watertown.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutritional products for infants, toddlers, children and adults. Its revolutionary, soy-free, plant-based formula is an alternative to pure milk-based ingredients. Else Nutrition (formerly INDI) was awarded the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The plant-based complete food for toddlers from Else was recently classified as the number 1 top seller in the baby and toddler food category on Amazon. The holding company Else Nutrition Holdings Inc. is a publicly traded company, traded on the TSX Venture Exchange under the symbol BABY and on the US OTC Markets QX Board under the symbol BABYF and on the Frankfurt Stock Exchange under the symbol 0YL. written down . Else executives include executives from leading baby food companies. Many of Else’s advisory board members have held previous leadership positions at companies such as Mead Johnson, Abbott Nutrition, Plum Organics, and leading child nutrition companies, and some of them are currently in various roles at leading medical centers and academic institutions such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

Media contact
Erin Jundef
Brilliant PR
[email protected]

For more information contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder and Director
ELSE Nutrition Holdings Inc.
E: [email protected]
Phone: +972 (0) 3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
E: [email protected]
P: 604-603-7787

US Investor Relations contact
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
E: [email protected]
P: 646-829-9701

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulator (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Beware of forward-looking statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are usually identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements regarding the anticipated dates for filing the company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions that are based on management’s perception of current conditions and expected future developments, as well as on other factors that management considers appropriate under the given circumstances. There can be no assurance that the foregoing will prove to be correct. Forward-looking statements in this press release assume, among other things, that there will be no interruptions or failures in the supply chain due to COVID 19 and that the manufacturing, brokerage and delivery logistics agreement with the company will not end. Actual results could differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which only reflect management’s expectations as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements as a result of new information, future events or for any other reason, except as required by law.